Stocktoria
Bausch & Lomb Corp BLCO
NYSE · XNYS · stock · Ophthalmic Goods · website · IPO 2022-05-06
Chart by TradingView
3/9
Piotroski F — financial health
1.24
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $5.1B | $4.8B | $4.1B | $3.8B | $3.8B |
| Operating income | $113.0M | $162.0M | $130.0M | $207.0M | $329.0M |
| Net income | -$360.0M | -$317.0M | -$260.0M | $6.0M | $182.0M |
| Operating cash flow | $283.0M | $232.0M | -$17.0M | $345.0M | $873.0M |
| Free cash flow | -$66.0M | -$59.0M | -$198.0M | $170.0M | $680.0M |
| Total assets | $14.0B | $13.5B | $13.4B | $11.1B | $10.8B |
| Total liabilities | $7.5B | $6.9B | $6.5B | $4.0B | $1.4B |
| Shareholders' equity | $6.5B | $6.5B | $6.9B | $7.1B | $9.4B |
| Ratios | |||||
| Operating margin | 2.2% | 3.4% | 3.1% | 5.5% | 8.7% |
| Net margin | -7.1% | -6.6% | -6.3% | 0.2% | 4.8% |
| FCF margin | -1.3% | -1.2% | -4.8% | 4.5% | 18.1% |
| Return on assets | -2.6% | -2.4% | -1.9% | 0.1% | 1.7% |
| Return on equity | -5.5% | -4.8% | -3.8% | 0.1% | 1.9% |
| Debt / equity | 0.77× | 0.72× | 0.66× | 0.34× | 0.00× |
| Current ratio | 1.55 | 1.60 | 1.74 | 1.65 | 1.49 |
| Revenue growth | 6.5% | 15.6% | 10.0% | 0.1% | — |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.24 (grey)
- Working capital / assets 0.075
- Retained earnings / assets -0.066
- EBIT / assets 0.008
- Equity / liabilities 0.869
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001860742 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.